ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Louisiana » Infectious Disease

Top Infectious Disease Prescribers in Louisiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MARY ESCHETE MD

Infectious Disease

16,604

$2.44M

346
158 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

27%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 46%

$147
Average prescription price

Avg: $321

REBECCA CLARK M.D.

Infectious Disease

6,417

$2.52M

284
31 are 65+

10%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 46%

$392
Average prescription price

Avg: $321

JEFFERY COCO M.D.

Infectious Disease

5,690

$821K

329
216 are 65+

10%
patients receiving schedule two controlled substances

Avg: 2%

16%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 46%

$144
Average prescription price

Avg: $321

WALTER CAMPBELL MD

Infectious Disease

5,675

$2.39M

226
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

19%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 46%

$422
Average prescription price

Avg: $321

MARY MURPHY M.D.

Infectious Disease

5,630

$1.98M

154
12 are 65+

15%
patients receiving schedule two controlled substances

Avg: 2%

25%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 46%

$352
Average prescription price

Avg: $321

MICHAEL HAGENSEE MD PHD

Infectious Disease

4,666

$1.81M

221
20 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 46%

$387
Average prescription price

Avg: $321

TLALOC ALFEREZ MD

Infectious Disease

3,606

$940K

138
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

50%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 46%

$261
Average prescription price

Avg: $321

JULIA GARCIA-DIAZ MD

Infectious Disease

3,201

$1.28M

184
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 46%

$401
Average prescription price

Avg: $321

VITALIS OKECHUKWU M.D.

Infectious Disease

2,741

$2.02M

218
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 46%

$737
Average prescription price

Avg: $321

CERYL BESCH MD

Infectious Disease

2,588

$1.02M

160
23 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 46%

$395
Average prescription price

Avg: $321

ANNE HULL MD

Infectious Disease

2,170

$998K

139
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 46%

$460
Average prescription price

Avg: $321

CARLOS CHOUCINO MD

Infectious Disease

2,155

$730K

137
32 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

22%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 46%

$339
Average prescription price

Avg: $321

JOSEPH DALOVISIO MD

Infectious Disease

1,987

$185K

131
119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 46%

$93
Average prescription price

Avg: $321

JOHN TODD M.D.

Infectious Disease

1,666

$681K

62
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

26%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 46%

$409
Average prescription price

Avg: $321

PAULA SEAL MD, MPH

Infectious Disease

1,619

$628K

177
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 46%

$388
Average prescription price

Avg: $321

FRANK RABITO M.D.

Infectious Disease

1,541

$414K

178
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 46%

$268
Average prescription price

Avg: $321

MARY JOUBERT MD

Infectious Disease

1,455

$548K

129
76 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 46%

$377
Average prescription price

Avg: $321

DAVID MUSHATT MD

Infectious Disease

1,401

$760K

42
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 46%

$543
Average prescription price

Avg: $321

MICHAEL HILL MD

Infectious Disease

1,372

$496K

202
128 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 46%

$361
Average prescription price

Avg: $321

ELIZABETH BORRERO M.D.

Infectious Disease

1,340

$595K

68
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 46%

$444
Average prescription price

Avg: $321

NICHOLAS SELLS M.D.

Infectious Disease

1,202

$117K

104
65 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 46%

$97
Average prescription price

Avg: $321

PATRICK NJOKU MD

Infectious Disease

1,150

$671K

101
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

62%
prescriptions for brand name drugs

Avg: 46%

$584
Average prescription price

Avg: $321

NICHOLAS VAN SICKELS M.D.

Infectious Disease

1,024

$394K

50
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 46%

$385
Average prescription price

Avg: $321

KAMIL BITAR MD

Infectious Disease

1,020

$383K

187
108 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 46%

$375
Average prescription price

Avg: $321

DEEPTHI MURTHY MD

Infectious Disease

888

$480K

156
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 46%

$540
Average prescription price

Avg: $321

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank